Understand the source comparison
GHRP-6 Acetate Dosage: Comparison by Application
Preventive joint support 100–150mcg 2× daily 30 min before meals 8–10 ng/mL Sufficient for maintenance and mild stiffness. Minimal side effect risk Moderate joint degeneration 200–250mcg 2–3× daily 10–15 ng/mL Optimal balance of efficacy and tolerability for m
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Preventive joint support
- 100–150mcg
- 2× daily
- 30 min before meals
- 8–10 ng/mL
- Sufficient for maintenance and mild stiffness. Minimal side effect risk
- Moderate joint degeneration
- 200–250mcg
- 2–3× daily
- 10–15 ng/mL
- Optimal balance of efficacy and tolerability for most joint health goals
- Active osteoarthritis repair
- 250–300mcg
- 3× daily
- 30 min before meals or 90 min after
- 15–20 ng/mL
- Maximum therapeutic dose without receptor desensitization. Reserve for severe cases
- Post-injury cartilage healing
- 200mcg
- Fasted state only
- 12–16 ng/mL
- Higher frequency compensates for inflammatory cytokine interference with GH signaling
- Long-term usage (>3 months)
- 150–200mcg
- 10–12 ng/mL
- Lower dose prevents receptor downregulation while maintaining IGF-1 synthesis